Device Trial Radar · NCT07436156
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Feb 12, 2026
Primary completion
May 31, 2029
Study completion Nov 30, 2029
Sponsor
- Lead sponsor
- Route 92 Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Conditions
- Acute Ischemic Stroke
Interventions
Route 92 Medical Reperfusion SystemsDevice
Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems
Primary outcomes
What the sponsor says the trial is designed to measure.
- Periprocedural eTICI measurement of revascularizationTime frame: Periprocedural
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Route 92 Medical, Inc.
West Jordan, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.